Evolent Health (EVH) Depreciation and Depletion (2015 - 2026)

Evolent Health has reported Depreciation and Depletion for 12 years, with the latest figure at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 13.7% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $25.3 million (down 15.95% YoY), and the FY2025 full-year result was $26.3 million, down 13.2% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $6.3 million, roughly flat from $6.3 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $8.9 million in Q4 2022, with the low at $6.3 million in Q3 2025.
• Average Depreciation and Depletion over 5 years is $7.5 million, with a median of $7.6 million recorded in 2022.
• Year-over-year, Depreciation and Depletion grew 14.1% in 2022 and fell 18.99% in 2025.
• Tracing EVH's Depreciation and Depletion over 5 years: stood at $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then decreased by 2.63% to $7.4 million in 2024, then slipped by 14.86% to $6.3 million in 2025, then changed by 0.0% to $6.3 million in 2026.
• The last three Depreciation and Depletion figures came in at $6.3 million (Q1 2026), $6.3 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.

Peer Comparison